These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8658786)

  • 1. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral content in cyclosporine-treated renal transplant patients.
    Massari PU; Garay G; Ulla MR
    Transplant Proc; 1994 Oct; 26(5):2646-8. PubMed ID: 7940826
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
    Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R
    Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352
    [No Abstract]   [Full Text] [Related]  

  • 7. Course of three biochemical bone markers after kidney transplantation.
    Gonzalez MT; Bonnin R; Cruzado JM; Garcia R; Moreso F; Fulladosa X; Alsina J; Navarro MA; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2266-71. PubMed ID: 7652802
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
    Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B
    Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors involved in the loss of bone mineral density after renal transplantation.
    Torregrosa JV; Campistol JM; Montesinos M; Fenollosa B; Pons F; Martinez de Osaba MJ; Oppenheimer F
    Transplant Proc; 1995 Aug; 27(4):2224-5. PubMed ID: 7652782
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M; Ericzon BG; Hultenby K; Sjöden G; Reinholt FP; Nordenström J
    Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B; Korn A
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
    Kliem V; Repp H; Frei U
    Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts.
    Babarykin D; Amerika D; Adamsone I; Valinietse M; Rosental R
    Transplant Proc; 1996 Dec; 28(6):3137. PubMed ID: 8962215
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
    De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.